These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37596578)

  • 1. Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol.
    Andel D; Lam MGEH; de Bruijne J; Smits MLJ; Braat AJAT; Moelker A; Vegt E; Ruiter SJS; Noordzij W; Grazi G; Vallati GE; Bennink RJ; van Delden OM; Kranenburg OW; Ijzermans JNM; Nijkamp MW; Erdmann JI; Sciuto R; Hagendoorn J; Borel Rinkes IHM
    BMC Cancer; 2023 Aug; 23(1):771. PubMed ID: 37596578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial.
    Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Huijbregts JE; van het Schip AD; Elschot M; Bult W; de Jong HW; Meulenhoff PC; Zonnenberg BA
    J Exp Clin Cancer Res; 2010 Jun; 29(1):70. PubMed ID: 20550679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma.
    Palard X; Edeline J; Rolland Y; Le Sourd S; Pracht M; Laffont S; Lenoir L; Boudjema K; Ugen T; Brun V; Mesbah H; Haumont LA; Loyer P; Garin E
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):392-401. PubMed ID: 29177870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial).
    Hendriks P; Rietbergen DDD; van Erkel AR; Coenraad MJ; Arntz MJ; Bennink RJ; Braat AE; Crobach S; van Delden OM; Dibbets-Schneider P; van der Hulle T; Klümpen HJ; van der Meer RW; Nijsen JFW; van Rijswijk CSP; Roosen J; Ruijter BN; Smit F; Stam MK; Takkenberg RB; Tushuizen ME; van Velden FHP; de Geus-Oei LF; Burgmans MC;
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2085-2097. PubMed ID: 38329507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients-A Dose-Finding Study (HORA EST HCC Trial).
    Hendriks P; Rietbergen DDD; van Erkel AR; Coenraad MJ; Arntz MJ; Bennink RJ; Braat AE; Crobach ASLP; van Delden OM; van der Hulle T; Klümpen HJ; van der Meer RW; Nijsen JFW; van Rijswijk CSP; Roosen J; Ruijter BN; Smit F; Stam MK; Takkenberg RB; Tushuizen ME; van Velden FHP; de Geus-Oei LF; Burgmans MC;
    Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1057-1063. PubMed ID: 35618860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Holmium-166 Radioembolization in Hepatocellular Carcinoma: Feasibility and Safety of a New Treatment Option in Clinical Practice.
    Radosa CG; Radosa JC; Grosche-Schlee S; Zöphel K; Plodeck V; Kühn JP; Kotzerke J; Hoffmann RT
    Cardiovasc Intervent Radiol; 2019 Mar; 42(3):405-412. PubMed ID: 30603976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres.
    Prince JF; van Rooij R; Bol GH; de Jong HW; van den Bosch MA; Lam MG
    J Nucl Med; 2015 Jun; 56(6):817-23. PubMed ID: 25931477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection.
    Vouche M; Lewandowski RJ; Atassi R; Memon K; Gates VL; Ryu RK; Gaba RC; Mulcahy MF; Baker T; Sato K; Hickey R; Ganger D; Riaz A; Fryer J; Caicedo JC; Abecassis M; Kulik L; Salem R
    J Hepatol; 2013 Nov; 59(5):1029-36. PubMed ID: 23811303
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Andel D; van den Bent L; Ernest Hendrik Lam MG; Johannes Smits ML; Molenaar IQ; de Bruijne J; Laclé MM; Kranenburg O; Max Borel Rinkes IH; Hagendoorn J
    JHEP Rep; 2024 Feb; 6(2):100981. PubMed ID: 38298739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Radiation Dose Absorbed by Healthy Parenchyma Is a Predictor for the Rate of Contralateral Hypertrophy After Unilobar Radioembolization of the Right Liver.
    Coskun N; Yildirim A; Yuksel AO; Canyigit M; Ozdemir E
    Nucl Med Mol Imaging; 2022 Dec; 56(6):291-298. PubMed ID: 36425272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yttrium-90 Glass-Based Microsphere Radioembolization in the Treatment of Hepatocellular Carcinoma Secondary to the Hepatitis B Virus: Safety, Efficacy, and Survival.
    Biederman DM; Titano JJ; Lee KM; Pierobon ES; Schwartz M; Facciuto ME; Gunasekaran G; Florman S; Fischman AM; Patel RS; Tabori NE; Nowakowski FS; Kim E
    J Vasc Interv Radiol; 2015 Nov; 26(11):1630-8. PubMed ID: 26321014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of
    Mahvash A; Chartier S; Turco M; Habib P; Griffith S; Brown S; Kappadath SC
    BMC Gastroenterol; 2022 Mar; 22(1):151. PubMed ID: 35346070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving MRI-based dosimetry for holmium-166 transarterial radioembolization using a nonrigid image registration for voxelwise
    Roosen J; van Wijk MWM; Westlund Gotby LEL; Arntz MJ; Janssen MJR; Lobeek D; van de Maat GH; Overduin CG; Nijsen JFW
    Med Phys; 2023 Feb; 50(2):935-946. PubMed ID: 36202392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Radioembolization with
    Prince JF; van den Bosch MAAJ; Nijsen JFW; Smits MLJ; van den Hoven AF; Nikolakopoulos S; Wessels FJ; Bruijnen RCG; Braat MNGJA; Zonnenberg BA; Lam MGEH
    J Nucl Med; 2018 Apr; 59(4):582-588. PubMed ID: 28916623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Radioembolization in Bridging and Downstaging Hepatocellular Carcinoma to Curative Therapy.
    Titano J; Voutsinas N; Kim E
    Semin Nucl Med; 2019 May; 49(3):189-196. PubMed ID: 30954184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yttrium-90 Radioembolization for Hepatocellular Carcinoma: Virtual Tumor Absorbed Dose as a Predictor of Complete Response.
    Kim HC; Choi JW; Lee M; Kim YJ; Paeng JC; Chung JW
    Anticancer Res; 2021 May; 41(5):2625-2635. PubMed ID: 33952493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery.
    Roosen J; Westlund Gotby LEL; Arntz MJ; Fütterer JJ; Janssen MJR; Konijnenberg MW; van Wijk MWM; Overduin CG; Nijsen JFW
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4705-4715. PubMed ID: 35829749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with
    Hermann AL; Dieudonné A; Ronot M; Sanchez M; Pereira H; Chatellier G; Garin E; Castera L; Lebtahi R; Vilgrain V;
    Radiology; 2020 Sep; 296(3):673-684. PubMed ID: 32602828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in France.
    Garin E; Pinaquy JB; Bailly C; Sengel C; Mariano-Goulart D; Edeline J; Blanc JF; Bouvier A; Tordo J; Rode A; Becker S; Sefrioui D; de Baere T; Somma C; Mastier C; Goupil J; Chevallier P; Regnault H; Vibert E; Manfredi S; Vicaut E; Patel B; Boucher E; Guiu B;
    Cardiovasc Intervent Radiol; 2022 Jan; 45(1):1-11. PubMed ID: 34796373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.